A Major Milestone in Hair Loss Treatment There is promising news for individuals living with alopecia areata. Legacy Healthcare has officially announced that their investigational drug, Cinainu, has received FDA Breakthrough Therapy Designation for the treatment of alopecia areata in adults. Understanding the Significance The FDA’s Breakthrough Therapy Designation is a vital step in the…